cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin - Wikidata - awgldk - TriplyDB

cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin

cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin

http://www.wikidata.org/entity/Q33318452

about

Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes.Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells.Twist controls skeletal development and dorsoventral patterning by regulating runx2 in zebrafish.Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats.CREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs).Caffeine inhibits the viability and osteogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis.Adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders.The roles of EZH2 in cell lineage commitment.The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization G protein-coupled receptors and adipogenesis: a focus on adenosine receptors.The effects of vibration loading on adipose stem cell number, viability and differentiation towards bone-forming cells.Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity.Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1α overexpression Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity.Adenosine A(2A) receptor ligation inhibits osteoclast formation.Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors.Adipocyte iron regulates leptin and food intake Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo.Cyclic AMP signaling in bone marrow stromal cells has reciprocal effects on the ability of mesenchymal stem cells to differentiate into mature osteoblasts versus mature adipocytes.Inherited human diseases of heterotopic bone formation.Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.Intermittent parathyroid hormone (1-34) application regulates cAMP-response element binding protein activity to promote the proliferation and osteogenic differentiation of bone mesenchymal stromal cells, via the cAMP/PKA signaling pathway.Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells Protein kinase A induces UCP1 expression in specific adipose depots to increase energy expenditure and improve metabolic health.Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo.The Hippo pathway: regulators and regulations.The bone and fat connection in inflammatory bowel diseases.Leptin promotes ossification through multiple ways of bone metabolism in osteoblast: a pilot study.The potential roles of EZH2 in regenerative medicine.What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes.Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells.Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cells.

P2860

Q26766574-AD61B123-8503-4F5F-823E-C2DDFCA4ED03 Q28596636-628A06D6-1F0A-4A0E-BD40-8AFC7377D1F6 Q30432500-A593E9E7-CA4F-4494-818D-8461E4C49A04 Q33714809-20AD661A-6896-401D-A20F-2ABA29036A4E Q34009553-0DA4D513-24F6-4B5A-9539-17790CC5EC29 Q34075607-CBA82B9F-CD0B-4BDC-B074-0CF933747751 Q34234574-9EE91BAB-18CC-4B56-BE52-7DD94FBDC6D9 Q34302065-3FCC9885-37DB-4D50-988C-5872A05E3C85 Q34442329-FE21FDB1-1E08-41FA-8639-B33C6EBC2EDB Q34539588-60EC9388-588B-48A9-A0E7-B4457E02266B Q34903773-49AAD23B-927C-4908-AE0B-3E6F68F89A48 Q34976731-A30353DF-85E0-4CD2-98E1-78445209C7F3 Q35008966-8BB3FF8D-3881-4568-A840-141947426220 Q35098055-234B4450-5A2D-43C4-A476-A2F8488F74A0 Q35184642-97E29637-B914-4409-AD02-EC192DAF8F23 Q35467148-D3D47580-0509-4D1E-8029-BD43DCF99EB0 Q35558140-EB6854B8-DD84-4DB1-8F06-783C21057692 Q35600126-296D07AA-5C1E-48F9-82ED-6A37EEB6F339 Q35874484-4F9923C8-1AC7-4FFB-862F-A456043C2FB1 Q35951939-766BF0B3-EDF3-4081-81E2-4A276293EAD9 Q35969297-C9E230EA-0804-4CA3-9D5F-CFB9805E0092 Q36106029-DEBC2E2C-0B74-41C4-A417-B26F0577C4F1 Q36122295-C4A19243-7842-4E5F-8C33-22E48E0E0824 Q36431648-957497B5-CECF-4E5E-B304-187098843890 Q36552107-99F073CD-4E2F-437D-BBE4-51F5AF61E402 Q36948973-0F3BF492-C423-424C-B060-A5A1FD7FDBF4 Q36953548-DB05B175-7EC2-4F44-8A1E-322C52DD058D Q36970516-B57A510C-766F-430A-BC70-9DC674FA6E2E Q37054486-6E751513-4979-4103-9DF0-DC77E4496888 Q37139727-C8CEB74C-26E6-4880-930F-6E17EAEBCEC7 Q37318434-ED3F5C60-579B-47C3-BD8E-050E800261F2 Q37318889-1FE9BCAE-41A7-4C4B-A521-0BC3EA206207 Q37594004-2E0EBC7A-0604-4301-8C94-1E0476159673 Q38083640-26231AB5-CB96-48DF-A246-BA347B49C594 Q38225220-AE513FF3-BA25-4969-837D-35F80AEC7739 Q38315275-6A840EE4-E909-4AB6-82A6-0C7025EE14B2 Q38342509-8FB6F4FF-6921-4144-B067-9ACED7A5DFF0 Q39213057-12E2DFC7-19A4-4568-8C9D-AC127513CF4F Q39451500-FFE2B52A-15A6-40A8-A397-F64DD80BA1B6 Q39716472-23EC062E-1EE0-49DD-805A-4C63F4F90312

P2860

cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin

http://www.wikidata.org/entity/Q33318452

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@ast

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@en

cAMP/PKA regulates osteogenesi ...... m cells by suppressing leptin.

@nl

type

label

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@ast

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@en

cAMP/PKA regulates osteogenesi ...... m cells by suppressing leptin.

@nl

prefLabel

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@ast

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@en

cAMP/PKA regulates osteogenesi ...... m cells by suppressing leptin.

@nl

P1433

Q33318452-234DB96E-120F-4A27-8C81-7BA2F6BC1776

P1476

Q33318452-28F1FD86-5EC9-487A-B0C7-F3998DFA3A27

P2093

Q33318452-2E954D10-A442-49FD-9CF2-4C5D030423D8

Q33318452-518C0412-548B-48CF-A3BC-65CE29F4D466

Q33318452-7E2B6AF1-C253-4C5D-87FF-B586535F244B

Q33318452-99EAA659-9B73-4417-81AE-41D36A0424CF

Q33318452-C8883A88-0DB0-407B-84F8-24366ED9455A

Q33318452-D647EDB1-0AEB-4195-AA04-254A7A380378

Q33318452-D6AF684C-A070-4B4E-B393-30E6AC0B3870

P2860

Q33318452-00144E1A-AC30-408A-8488-8F6AC078CE42

Q33318452-0BF4CB77-1425-4690-AC44-3CA3734385BD

Q33318452-0DAB9710-F4A6-4390-9D42-356493435A9C

Q33318452-0E9BB00E-7889-4ECF-A438-C680FC53E225

Q33318452-10E864C0-9F77-4DC5-B349-6FA1D4F8E4FF

Q33318452-116DE01D-B0E6-40C7-A956-B873AEC7A134

Q33318452-13DF419C-E26B-40FB-9FD4-1595A35FEB3D

Q33318452-17426879-6DEB-493E-831C-C2B966D6367E

Q33318452-21AA2760-7DC8-417E-B652-2E8C0631C42F

Q33318452-2CDAD591-C76D-4237-879A-5AFEF455A55B

P304

Q33318452-B5A94F6A-E6B6-408A-B62C-B9F6529D202D

P31

Q33318452-8D5BD24D-CD84-4DD9-8948-1DB105A7CAE2

P356

Q33318452-22782265-F63E-42C9-9967-A5AA5EA33B5C

P407

Q33318452-D5F97124-75C7-4DA4-A074-AED299D1A34C

P433

Q33318452-EFE00D60-43D5-4B4B-901F-F6D39875C633

P478

Q33318452-9F51FFDD-C276-49BB-9E3C-C14B3E332911

P577

Q33318452-3CECE9F6-4A87-477A-BF7B-9B8A8ADBA8A2

P5875

Q33318452-58501E1E-19D1-4EF2-B2BF-6431129451F3

P698

Q33318452-C01189FB-04F8-41F6-910C-E8F9D6C116BB

P932

Q33318452-9BEA92CE-7A03-489A-8320-CE9536E75FF4

P356

JOURNAL.PONE.0001540

P1433

P1476

cAMP/PKA regulates osteogenesi ...... em cells by suppressing leptin

@en

P2093

Der-Chih Yang

http://www.w3.org/2001/XMLSchema#string

Huey-Jen Tsay

http://www.w3.org/2001/XMLSchema#string

Mei-Jane Li

http://www.w3.org/2001/XMLSchema#string

Shan-Yang Lin

http://www.w3.org/2001/XMLSchema#string

Shih-Chieh Hung

http://www.w3.org/2001/XMLSchema#string

Shih-Hwa Chiou

http://www.w3.org/2001/XMLSchema#string

Tai-Jay Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

Entrainment of the diurnal rhythm of plasma leptin to meal timing

Evidence for leptin expression in fishes

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

P304

e1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0001540

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5599802

http://www.w3.org/2001/XMLSchema#string

P698

18253488

http://www.w3.org/2001/XMLSchema#string

P932

2212109

http://www.w3.org/2001/XMLSchema#string